Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Regulation

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; May 18, 2022.

Save
Print
May 25, 2022
Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; May 18, 2022.

This guidance outlines design elements that reduce errors associated with medication labels. Improvements suggested include tall-man lettering use, look-alike / sound alike avoidance and abbreviation minimization.

Save
Print
Cite
Citation

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; May 18, 2022.